Privia Health Group, Inc. reiterated earnings guidance for the year 2024. For the period, the company expects GAAP revenue of $1,600 million to $1,675 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.47 USD | -1.26% |
|
-1.88% | -28.51% |
05-30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
05-20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.51% | 1.99B | |
+25.35% | 89.17B | |
-23.03% | 75.87B | |
+2.32% | 27.41B | |
-10.50% | 17.52B | |
-0.32% | 17.04B | |
+0.27% | 15.36B | |
+77.41% | 13.67B | |
+78.47% | 13.18B | |
-25.61% | 12.83B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group, Inc. Reiterates Earnings Guidance for the Year 2024